🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yu‐Wei Chen

UC San Diego Health System

ORCID: 0000-0001-7988-319X

Also affiliated with University of California San Diego, University of California San Diego Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial”.

Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial

BMJ Oncology(2024)10.1136/bmjonc-2023-000181
N/A
0.536DataRank · unranked
8 citations

Yu‐Wei Chen, Martin H. Voss, Bradley A. McGregor, Mehmet Asım Bilen, Marc‐Oliver Grimm +9 more

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma

Cancers(2022)10.3390/cancers14153830
N/A
0.442DataRank · unranked
18 citations

Matthew D. Tucker, Landon C. Brown, Hesham Yasin, Kristin Kathleen Ancell, Andrew J. Armstrong +12 more

Comparison of outcomes of radical and partial nephrectomy for sarcomatoid renal cell carcinoma: analysis of the national cancer database

World Journal of Urology(2024)10.1007/s00345-024-05169-w
N/A
0.208DataRank · unranked
3 citations

Kit L. Yuen, Cesare Saitta, Margaret F. Meagher, Franklin Liu, Melis Güer +6 more

Association between decline of neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4527
N/A
0.165DataRank · unranked
2 citations

Matthew D. Tucker, Landon C. Brown, Hesham Yasin, Kristin Kathleen Ancell, Andrew J. Armstrong +12 more

Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma

Current Oncology Reports(2022)10.1007/s11912-022-01196-1
N/A
0DataRank · unranked
16 citations

Brian I. Rini, Yu‐Wei Chen

Association between on-treatment eosinophil dynamics and outcomes in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.364
N/A
0DataRank · unranked
0 citations

Matthew D. Tucker, Hesham Yasin, Kristin Kathleen Ancell, Nancy B. Davis, Scott M. Haake +8 more